W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Model Number RLT351414 |
Device Problems
Premature Activation (1484); Difficult or Delayed Activation (2577)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/06/2022 |
Event Type
malfunction
|
Event Description
|
On (b)(6) 2022, the patient underwent endovascular treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.It was reported that, as primary deployment of the trunk-ipsilateral leg component was initiated, the primary deployment handle was pulled and the entire deployment line was removed from the delivery catheter, but no device deployment occurred.It was reported that the deployment line was removed easily with no resistance and it was suspected that the deployment line was not attached to the constraining sleeve of the device.Although deployment of the main body did not occur, it was reported that a small portion at the proximal end of the ipsilateral limb was slightly expanded.The cause of the deployment failure was unknown.Reportedly, the physician was unable to re-sheath the device due to the slight expansion of the ipsilateral limb.The secondary deployment handle was pulled and, although removal was successful, extreme resistance was reported.It was reported that the entire device was unsheathed distally and final deployment was initiated.The third deployment handle was removed with no reported issues.And the device reportedly expanded fully.The delivery catheter was successfully removed with no reported issues.There were no reported patient adverse events and deployment was successfully completed.However, the device was reportedly positioned more distally than expected upon final review.No inadvertent vessel coverage or other issues occurred.There were no further reported issues.The patient tolerated the procedure.The delivery catheter and handles were discarded at the facility.
|
|
Manufacturer Narrative
|
Other relevant history, including preexisting medical conditions: asked but unavailable concomitant medical products and therapy dates: asked but unavailable (b)(4).According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), potential device or procedure related adverse events that may occur and/or require intervention or additional intraoperative procedure time include, but are not limited to, incomplete component deployment, unintentional/premature component deployment, and improper component placement.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
H.6.Component code added.H.6.Investigation findings: code c19 - an analysis of relevant data was performed in view of supporting the identification of possible causes of the event.The evaluation found the following: without a physical sample or images to evaluate, the physician¿s observations could not be confirmed.The likely cause for the reported event could not be determined with the available information.H.6.Investigation conclusions: code d12 added.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), potential device or procedure related adverse events that may occur and/or require intervention or additional intraoperative procedure time include, but are not limited to, incomplete component deployment, unintentional/premature component deployment, and improper component placement.H.6.Investigation findings: code c21 updated to code c19.H.6.Investigation conclusions: code d16 updated to code d15.
|
|
Search Alerts/Recalls
|
|
|